{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:54:10Z","timestamp":1790895250822,"version":"4.1.0"},"reference-count":46,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","issue":"03","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Bras Ginecol Obstet"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present update is a reassessment of the 2018 \u2018Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil\u2019 (Zeferino et al.)9, according to the changes observed in new international guidelines and knowledge updates. The most relevant and recent guidelines were assessed. Questions regarding the clinical practice were formulated, and the answers considered the perspective of the public and private sectors of the Brazilian health system. The review addressed risk-based strategies regarding age to start and stop screening, the use of cytology and colposcopy to support management decisions, treatment, follow-up strategies, and screening in specific groups, including vaccinated women. The update aims to improve the prevention of cervical cancer and to reduce overtreatment and the misuse of HPV testing.<\/jats:p>","DOI":"10.1055\/s-0041-1739314","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T20:24:18Z","timestamp":1644956658000},"page":"264-271","source":"Crossref","is-referenced-by-count":22,"title":["Cervical Cancer Screening with HPV Testing: Updates on the Recommendation"],"prefix":"10.61622","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-1452","authenticated-orcid":false,"given":"Carla Fabrine","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0979-376X","authenticated-orcid":false,"given":"Julio Cesar","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-6500","authenticated-orcid":false,"given":"Joana Froes","family":"Bragan\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1029-9993","authenticated-orcid":false,"given":"Sophie","family":"Derchain","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-0971","authenticated-orcid":false,"given":"Luiz Carlos","family":"Zeferino","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-0225","authenticated-orcid":false,"given":"Diama Bhadra","family":"Vale","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Universidade Estadual de Campinas, Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"47794","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"issue":"15","key":"ref1","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1016\/j.ejca.2013.04.024","article-title":"Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors","volume":"49","author":"S Vaccarella","year":"2013","journal-title":"Eur J Cancer"},{"issue":"01","key":"ref2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/01443615.2018.1463976","article-title":"Level of human development is associated with cervical cancer stage at diagnosis","volume":"39","author":"D B Vale","year":"2019","journal-title":"J Obstet Gynaecol"},{"issue":"07","key":"ref3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10552-016-0766-x","article-title":"Disparities in time trends of cervical cancer mortality rates in Brazil","volume":"27","author":"D B Vale","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"01","key":"ref5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijgo.13458","article-title":"Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems","volume":"152","author":"D B Vale","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"G Ronco","year":"2014","journal-title":"Lancet"},{"issue":"08","key":"ref7","doi-asserted-by":"publisher","first-page":"CD008587","DOI":"10.1002\/14651858.CD008587.pub2","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"G Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","volume-title":"Diretrizes brasileiras para o rastreamento do c\u00e2ncer do colo do \u00fatero","author":"Minist\u00e9rio da Sa\u00fade","year":"2016","edition":"2a ed."},{"issue":"06","key":"ref9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1055\/s-0038-1657754","article-title":"Recomenda\u00e7\u00f5es para o uso de testes de DNA-HPV no rastreamento do c\u00e2ncer do colo do \u00fatero no Brasil","volume":"40","author":"L C Zeferino","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref10","volume-title":"National Cervical Screening Program: guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding [Internet]","author":"Cancer Council Australia","year":"2020"},{"issue":"02","key":"ref11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"R B Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"01","key":"ref12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000001263","article-title":"Practice Bulletin No. 157: Cervical Cancer Screening and Prevention","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"E TH Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"04","key":"ref14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","article-title":"Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)","volume":"123","author":"M Kyrgiou","year":"2020","journal-title":"Br J Cancer"},{"issue":"07","key":"ref15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"S J Curry","year":"2018","journal-title":"JAMA"},{"key":"ref16","volume-title":"Comprehensive cervical cancer control: a guide to essential practice","author":"World Health Organization","year":"2014"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11912-014-0416-y","article-title":"Adenocarcinoma of the uterine cervix: why is it different?","volume":"16","author":"K Fujiwara","year":"2014","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"ref18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1055\/s-0039-1698772","article-title":"\u2018Missing Adenocarcinomas\u2019: Are They a Real Problem in Cervical Cancer Screening in Brazil?","volume":"41","author":"D B Vale","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"02","key":"ref19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ygyno.2014.08.014","article-title":"Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil","volume":"135","author":"A Nogueira-Rodrigues","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"06","key":"ref20","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/eurpub\/cky061","article-title":"Moving towards an organized cervical cancer screening: costs and impact","volume":"28","author":"M Diaz","year":"2018","journal-title":"Eur J Public Health"},{"issue":"03","key":"ref21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/1471-0528.16400","article-title":"Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study","volume":"128","author":"E Jansen","year":"2021","journal-title":"BJOG"},{"issue":"09","key":"ref22","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/bjc.2012.94","article-title":"Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway","volume":"106","author":"E A Burger","year":"2012","journal-title":"Br J Cancer"},{"issue":"02","key":"ref23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"W K Huh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"05","key":"ref24","doi-asserted-by":"publisher","first-page":"e0251688","DOI":"10.1371\/journal.pone.0251688","article-title":"Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country","volume":"16","author":"D B Vale","year":"2021","journal-title":"PLoS One"},{"issue":"07","key":"ref25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"H A Katki","year":"2011","journal-title":"Lancet Oncol"},{"issue":"08","key":"ref26","doi-asserted-by":"publisher","first-page":"dju153","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"J C Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"S 05","key":"ref27","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bpobgyn.2020.02.008","article-title":"Primary HPV screening for cervical cancer","volume":"65","author":"N Bhatla","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"02","key":"ref29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"D Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1038\/nrdp.2016.86","article-title":"Carcinogenic human papillomavirus infection","volume":"2","author":"M Schiffman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"01","key":"ref31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/bjc.2013.322","article-title":"Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years","volume":"109","author":"A Castanon","year":"2013","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"M Kyrgiou","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"ref33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/cncy.21312","article-title":"High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion","volume":"121","author":"D B Vale","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"02","key":"ref34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1006\/gyno.1995.1212","article-title":"Observer agreement on interpreting colposcopic images of CIN","volume":"58","author":"E H Hopman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"ref35","first-page":"1279","article-title":"e National Institutes of Health\/American Society for Colposcopy and Cervical Pathology (NIH\/ASCCP) Research Group. \u201cInterobserver Agreement in the Assessment of Components of Colposcopic Grading\u201d","author":"L Stewart","journal-title":"Obstetrics and Gynecology"},{"issue":"01","key":"ref36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/1471-0528.13530","article-title":"Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis","volume":"123","author":"R M Ebisch","year":"2016","journal-title":"BJOG"},{"issue":"03","key":"ref37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/AOG.0000000000002812","article-title":"Risk of cervical intraepithelial neoplasia 2 or worse by cytology, human papillomavirus 16\/18, and colposcopy impression: a systematic review and meta-analysis","volume":"132","author":"M I Silver","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study","volume":"168","author":"P E Castle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1006\/gyno.2001.6207","article-title":"Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study","volume":"82","author":"J P Dhar","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"01","key":"ref40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1471-0528.1995.tb09027.x","article-title":"The incidence of cervical intraepithelial neoplasia among women with renal transplant in relation to cyclosporine","volume":"102","author":"S A ter Haar-van Eck","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"02","key":"ref41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/jcm4020260","article-title":"HPV carcinomas in immunocompromised patients","volume":"4","author":"N M Reusser","year":"2015","journal-title":"J Clin Med"},{"issue":"06","key":"ref42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"V B Benard","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"ref43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.15585\/mmwr.mm7012a2","article-title":"Declines in prevalence of human papillomavirus vaccine-type infection among females after introduction of vaccine - United States, 2003-2018","volume":"70","author":"H G Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"07","key":"ref44","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"L Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"01","key":"ref45","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s12889-020-08561-4","article-title":"Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program","volume":"20","author":"A Faisal-Cury","year":"2020","journal-title":"BMC Public Health"},{"issue":"03","key":"ref46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/13557858.2018.1427703","article-title":"Racial\/ethnic disparities in human papillomavirus vaccination initiation and completion among U.S. women in the post-Affordable Care Act era","volume":"25","author":"M Ag\u00e9nor","year":"2020","journal-title":"Ethn Health"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pvr.2019.03.003","article-title":"Knowledge about HPV and vaccination among young adult men and women: Results of a national survey","volume":"7","author":"N L Kops","year":"2019","journal-title":"Papillomavirus Res"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia \/ RBGO Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalrbgo.org\/article\/cervical-cancer-screening-with-hpv-testing-updates-on-the-recommendation\/","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1739314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T16:57:41Z","timestamp":1721321861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/cervical-cancer-screening-with-hpv-testing-updates-on-the-recommendation\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":46,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,5,16]]},"published-print":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1739314","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}